Latest contributions
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR
09 Mar 2026
Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!

Author

Author
All you need to know about redo TAVI
15 Feb 2026 – From PCR Tokyo Valves 2026
This comprehensive session on redo Transcatheter Aortic Valve Implantation (TAVI) covers critical aspects beyond coronary obstruction risk, including detailed pre-procedural analysis, valve sizing, and innovative procedural techniques such as leaflet modification and optimal angle placement. Post-procedural considerations like antithrombotic therapy and patient-prosthesis mismatch are also thoroughly...
Procedural optimisation for enhanced acute and long-term outcomes
14 Feb 2026 – From PCR Tokyo Valves 2026
This session emphasizes procedural optimization in TAVI to enhance both acute and long-term outcomes. It highlights critical factors such as valve sizing, expansion, implantation depth, and commissural alignment. Practical techniques for pre- and post-dilatation alongside commissural alignment are demonstrated through real cath lab cases, underscoring their...
Mitral and aortic transcatheter valve-in-valve intervention - LIVE case
14 Feb 2026 – From PCR Tokyo Valves 2026
Live case
An 83-year-old male with AF, CKD (stage 3A), preserved LV function, and a history of AVR (27 mm Magna Ease) and MVR (33 mm Magna) in 2014 presented with symptomatic stenosis of the mitral bioprosthesis. A Sapien 3 valve was implanted in the Magna mitral...
Late-breaking trials of PCR Tokyo Valves 2026
14 Feb 2026 – From PCR Tokyo Valves 2026
This session presents pivotal late-breaking trials from PCR Tokyo Valves 2026, offering one-year outcomes and real-world experiences in transcatheter valve therapies. Highlights include the AltaValve early feasibility study on atrial fixation TMVR, invasive registry insights on prosthesis-patient mismatch post-TAVR, and registry data on tricuspid and mitral...
All about PCR’s Teaching Assessment Board (TAB)
03 Dec 2025
Learn how session feedback is compiled to create a virtuous cycle of continuous refinement for education in #interventionalcardiology
TAVI in 2025: transforming care with the new valvular heart disease guidelines
18 Nov 2025 – From PCR London Valves 2025
This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...
Redo TAVI for transcatheter heart valve failure
18 Nov 2025 – From PCR London Valves 2025
This session addresses the critical considerations involved in re-do TAVI procedures for transcatheter heart valve failure. It guides through key decision-making processes, step-by-step CT analysis for procedural planning, and established protocols to effectively execute valve-in-valve interventions, enhancing outcomes in complex repeat valve therapies.
Featured research - TAVI: Redo strategies, valve performance & access safety
17 Nov 2025 – From PCR London Valves 2025
This detailed session investigates critical aspects of TAVI procedures including the safety of selective and routine femoral access angiography post-TAVI, outcomes from the ReTAVI registry focusing on redo-TAVI in various valve frames, and a comparative analysis of JenaValve versus Evolut transcatheter heart valves in severe aortic...
Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV
17 Nov 2025 – From PCR London Valves 2025
This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...
Redo TAVI with pre and post dilatation - LIVE Case
16 Nov 2025 – From PCR London Valves 2025
Watch this live case followed by a live in a box case, regarding a 93-year-old woman with hypertension, chronic bronchitis, and a history of TAVI with a Sapien 3 23 mm (2016) who presented with symptomatic severe aortic stenosis and mildly reduced LV function (50%). An...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
Redo TAVI
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on the challenges and strategies of redo TAVI, from careful planning to valve selection and tailored procedural approaches. Learn how to manage different valve platforms, optimise outcomes in valve-in-valve scenarios, and prevent complications such as coronary obstruction through real case discussions.
Aortic stenosis doesn't play alone: TAVI in multivalvular and coronary artery disease patients
11 Sep 2025 – From PCR Rio Valves 2025
Managing aortic stenosis becomes even more challenging when it coexists with coronary artery disease (CAD) or multivalvular pathology. For patients with CAD, careful assessment of symptoms, lesion severity, and anatomy guides whether PCI is best performed before, during, or after TAVI, always with future coronary access...
Innovation to address unmet clinical needs in transcatheter valve therapies
22 May 2025 – From EuroPCR 2025
Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.
Redo TAVI - How to treat different TAVI platforms when they fail
22 May 2025 – From EuroPCR 2025
Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.
How to manage coronary artery disease in TAVI candidates?
20 May 2025 – From EuroPCR 2025
Understand the comprehensive management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI). This session reviews evidence-based evaluation, decision-making, and treatment strategies for significant coronary lesions, including severe left main and multivessel disease, illustrated through detailed case studies.
TAVI in bicuspid aortic valve disease - LIVE Case
20 May 2025 – From EuroPCR 2025
A 79-year-old male patient with atrial fibrillation and RBBB on ECG presented with symptomatic severe bicuspid aortic stenosis. LV function was preserved, and coronary artery disease was noted in LAD and first diagonal. A 26 mm Sapien Ultra Resilia valve was implanted via dual femoral access,...
Redo TAVI: how to treat different TAVI platforms when they fail?
22 May 2025 – From EuroPCR 2025
In this discussion, Tanja Rudolph, Dan Blackman, and Radoslaw Parma take a deep dive into the current understanding of redo TAVR.
Together, they address the main challenges faced in repeat procedures - chiefly, the risk of coronary obstruction and the importance of preserving coronary access, alongside strategies...
Mastering TAV-in-SAV: strategies, challenges and advanced techniques
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to master the ins and outs of TAV-in-SAV? Don’t miss these presentations!
You’ll get expert guidance on evaluating feasibility, choosing the right transcatheter valve and using advanced techniques (valve fracture, leaflet modification, coronary protection...). Plus, you'll dive into multiple real-world case presentations that tackle challenges, share...
Expanding indications for TAVI - moderate aortic stenosis and heart failure
09 Feb 2025 – From PCR Tokyo Valves 2025
Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.
You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...
Management of paravalvular leak
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this comprehensive session on the management of paravalvular leaks, a challenging complication following surgical or transcatheter valve replacements. Discover insights into managing post-operative pulmonary edema, percutaneous closure of left ventricular septal defects, and the nuances of mitigating recurrent paravalvular leaks. Dive into complex cases involving...
TAVI in bicuspid anatomy
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the key insights from this PCR Tokyo Valves 2025 session focused on TAVI in bicuspid anatomy. Learn why TAVI for bicuspid aortic stenosis (AS) shows comparable long-term outcomes to tricuspid AS in registry data, and understand the importance of patient selection, precise valve sizing, and...
Mastering techniques from basic to complex - TAVI basics
07 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the fundamentals of TAVI (Transcatheter Aortic Valve Implantation) in this comprehensive session. Explore the importance of commissural alignment, learn strategies to mitigate the risk of coronary occlusion, and discover techniques to manage unexpected hypotension during TAVI procedures. Equip yourself with the essential knowledge to...
TAV-in-SAV for surgical bioprosthetic valve failure
26 Nov 2024 – From PCR London Valves 2024
Dive into the intricacies of TAV-in-SAV procedures for failed surgical bioprosthetic valves. Gain a comprehensive understanding of the key information needed to evaluate a failed surgical bioprosthesis before considering a valve-in-valve intervention. Learn strategies to avoid high gradients and patient-prosthesis mismatch, and explore the clinical relevance...
TAV-in-TAV for transcatheter heart valve failure
26 Nov 2024 – From PCR London Valves 2024
Struggling with transcatheter heart valve failure? Don’t miss this video!
Learn the essential steps for planning a re-do TAVI procedure, from analysing CT scans to using the re-do TAVI app for a TAV-in-TAV approach, and watch a real-life case of a 91-year-old patient undergoing a redo procedure...
Non-transfemoral TAVI - The toolkit
25 Nov 2024 – From PCR London Valves 2024
When should you consider alternative access for TAVI instead of the transfemoral route? This video dives right into the different non-transfemoral approaches, from transsubclavian to transcaval, and explains when each technique is most appropriate.
Learn how vascular modification can expand access options for more patients and discover...
Featured Cases - TAVI in patients with challenging vascular access
24 Nov 2024 – From PCR London Valves 2024
Delve into a collection of captivating TAVI cases that push the boundaries of vascular access challenges. Witness how interventionists navigate complex aortic anatomies, dissections, and rare genetic diseases to deliver life-saving care. Explore innovative approaches such as transbrachial TAVI, transcarotid access, and valve-in-valve TAVI. This session...